Clinical trial
Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory…
NCT00313079 · Steven E. Coutre, Other · Completed
Key facts
| NCT number | NCT00313079 |
|---|---|
| Title | Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia |
| Official title | A Phase I Study of mAb 216 With Chemotherapy for the Treatment of Adult Patients With Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia |
| Lead sponsor | Steven E. Coutre, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphocytic, Acute Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | MAb 216, Vincristine |
| Enrollment | 9 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Apr 11, 2006 |
| Last update posted | Jul 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: